MyFinsight
Home
Blog
About
Contact
Net proceeds from
notes payable...
$500,000
Net cash provided by
financing activities
$500,000
Net increase
(decrease) in cash
-$285,119
Canceled cashflow
$500,000
Non-cash interest
expense
$174,635
Accrued expenses
$99,497
Stock-based compensation
$23,527
Depreciation expense
$22,256
Amortization of operating
lease right of use...
$18,942
Vendor expense settled
in shares of common...
$18,000
Net cash used in
operating activities
-$784,272
Canceled cashflow
$356,857
Net cash used in
investing activities
-$847
Net loss
-$618,466
Accounts receivable, net
$312,002
Prepaid expenses and
other current assets
$78,699
Accounts payable
-$50,848
Inventory, net
$34,776
Deferred revenue
-$27,941
Operating lease
liabilities
-$18,397
Purchases of property and
equipment
$847
Back
Back
Cash Flow
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)
source: myfinsight.com